Free Account Opening + AMC Free Demat
Loading...

C2C Advanced Systems IPO vs Onyx Biotec IPO

Comparision between C2C Advanced Systems IPO and Onyx Biotec IPO.

IPO Details

C2C Advanced Systems IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Onyx Biotec IPO is a SME Book Built Issue proposed to list at NSE SME.

  C2C Advanced Systems IPO Onyx Biotec IPO
Logo C2C Advanced Systems IPO Logo Onyx Biotec IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At NSE SME NSE SME
Lead Managers Mark Corporate Advisors Private Limited

Beeline Capital Advisors Pvt Ltd
Horizon Management Private Limited
Registrar Link Intime India Private Ltd Mas Services Limited
Market Maker Spread X Securities Private Limited Giriraj Stock Broking Private Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor
IPO Allotment URL

Issue Size and Price

The total issue size of C2C Advanced Systems IPO is up to ₹99.07 Cr whereas the issue size of the Onyx Biotec IPO is up to ₹29.34 Cr. The final issue price of C2C Advanced Systems IPO is and of Onyx Biotec IPO is ₹61.00 per share.

  C2C Advanced Systems IPO Onyx Biotec IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹214.00 per share ₹58.00 per share
Issue Price (Upper) ₹226.00 per share ₹61.00 per share
Issue Price (Final) ₹61.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 600 shares 2000 shares
Fresh Issue Size 43,83,600 shares 48,10,000 shares
Fresh Issue Size (Amount) up to ₹99.07 Cr up to ₹29.34 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 43,83,600 shares 48,10,000 shares
Issue Size Total (Amount) up to ₹99.07 Cr up to ₹29.34 Cr

IPO Timetable

C2C Advanced Systems IPO opens on Nov 22, 2024, while Onyx Biotec IPO opens on Nov 13, 2024. The closing date of C2C Advanced Systems IPO and Onyx Biotec IPO is Nov 26, 2024, and Nov 18, 2024, respectively.

  C2C Advanced Systems IPO Onyx Biotec IPO
Anchor Bid Date Nov 21, 2024 Nov 12, 2024
Issue Open Nov 22, 2024 Nov 13, 2024
Issue Close Nov 26, 2024 Nov 18, 2024
Basis Of Allotment (Tentative) Nov 27, 2024 Nov 19, 2024
Initiation of Refunds (Tentative) Nov 28, 2024 Nov 20, 2024
Credit of Share (Tentative) Nov 28, 2024 Nov 20, 2024
Listing date (Tentative) Nov 29, 2024 Nov 21, 2024
Anchor Lockin End date 1 Dec 27, 2024 Dec 19, 2024
Anchor Lockin End date 2 Feb 25, 2025 Feb 17, 2025

Financials

C2C Advanced Systems IPO P/E ratio is 22.56, as compared to Onyx Biotec IPO P/E ratio of 26.81.

  C2C Advanced Systems IPO Onyx Biotec IPO
Financial

C2C Advanced Systems Limited Financial Information (Restated)

C2C Advanced Systems Limited's revenue increased by 412% and profit after tax (PAT) rose by 327% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended30 Sep 202431 Mar 202431 Mar 202331 Mar 2022
Assets11,058.018,583.511,849.78903.18
Revenue4,324.974,129.82806.7334.79
Profit After Tax972.991,227.69287.52-238.21
Net Worth8,618.727,645.73252.14-136.57
Reserves and Surplus6,864.5296.69
Total Borrowing1,329.02944.74554.77
Amount in ₹ Lakhs

Onyx Biotec Limited Financial Information (Restated)

Onyx Biotec Limited's revenue increased by 35.99% and profit after tax (PAT) rose by 64.35% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 May 202431 Mar 202431 Mar 202331 Mar 2022
Assets7,476.577,413.585,872.363,683.84
Revenue1,054.115,387.433,961.654,498.09
Profit After Tax130.77303.16184.46335.29
Net Worth2,618.642,487.871,820.161,637.59
Reserves and Surplus1,286.421,155.651,230.001,047.43
Total Borrowing3,156.143,078.042,922.831,224.39
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 56.52% 88.60%
Promoter Shareholding (Post-Issue)
P/E Ratio 22.56 26.81
Market Cap ₹376.09 Cr. ₹110.61 Cr.
ROE 4.99%%
ROCE 3.71%%
Debt/Equity 0.15 1.21
EPS ₹10.02 ₹2.28
RoNW 11.29%% 4.99%%

Shares Offered

In the C2C Advanced Systems IPO retail investors (RII) are offered while in Onyx Biotec IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in C2C Advanced Systems IPO and 9,12,000 shares in Onyx Biotec IPO.

  C2C Advanced Systems IPO Onyx Biotec IPO
Anchor Investor Reserveration 12,49,200 shares 13,66,000 shares
Market Maker Reserveration 2,19,600 shares 2,44,000 shares
QIB 9,12,000 shares
NII 6,88,000 shares
RII 16,00,000 shares
Employee 0 shares
Others
Total 32,00,000 shares

Bids Received (Subscription)

C2C Advanced Systems IPO subscribed in total, whereas Onyx Biotec IPO subscribed 9.95x.

  C2C Advanced Systems IPO Onyx Biotec IPO
QIB (times) 0.00x
NII (times) 8.15x
Big NII (times)
Small NII (times)
RII (times) 16.40x
Employee (times)
Other (times)
Total (times) 9.95x

Comments

Add a public comment...